Finch Therapeutics GroupFNCHQ
13F holders, Q2 2024 (June 30)1holders −10
0new positions
11sold out
$1.37avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Finch Therapeutics Group Inc. (FNCHQ) in their 13F filings, down 10 from Q1 2024. 0 opened new positions and 11 sold out. The largest holder was Lake Street Advisors Group, LLC ($29K).
- Company
- Finch Therapeutics Group Inc.
- CUSIP
- 31773D200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 11 | $283K |
All 13F filers, Q1 2024 → Q2 2024: 107,933 shares sold, net −107,933 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Lake Street Advisors Group, LLC | 0.00% | No change | 21,206 | $29K |
"% of holder's portfolio" is FNCHQ's weight in each manager's 13F, not the share of Finch Therapeutics Group Inc. the manager owns.